Skip to main content
https://catalogartifact.azureedge.net/publicartifacts/hcl-technologies.hcltech_irp_drug_summary_agents-7f858190-32f7-49ed-9918-e7d63725c776/image0_HCLTechlog.png

HCLTech Drug Summary Agents

by HCL America Inc_HCLT

Generate Structured Drug details for Selected Drugs for Strategic Decision-Making.

An agentic AI solution that generates structured drug summaries from trusted health authority and public regulatory sources to help teams access key product information faster
Drug Summary Agent helps life sciences organizations quickly generate structured drug details for selected drugs. The solution is designed for regulatory affairs, medical, competitive intelligence, and product strategy teams that need faster access to consolidated drug-level information without manually reviewing multiple external sources.
Users can search for a drug and generate a summary covering relevant product, regulatory, and clinical information. The solution can organize key details such as drug name, active ingredients, sponsor, manufacturer, indication, therapeutic area, dosage form, route of administration, approval status, health authority source, key regulatory references, and other configurable KPIs based on customer needs.
The agentic workflow reduces manual research effort by identifying relevant sources, extracting drug-level information, structuring the data into a consistent format, and generating summary. Source-linked output help users validate information and maintain traceability. Human users remain in control of review, interpretation, and downstream decision-making.

What the customer gets:
• Configured drug summary agent for selected life sciences use cases
• Drug search and summary generation workflow
• Structured product and regulatory information views
• Configurable KPI list based on customer requirements
• Source-linked summary outputs for traceability
• Downloadable drug summary report
• User access, security, and governance design considerations

Expected business outcomes:
• Faster access to consolidated drug-level information
• Reduced manual effort in reviewing external regulatory sources
• Improved consistency in drug summary preparation
• Better support for regulatory, competitive intelligence, and portfolio decisions
• Improved traceability through source-linked outputs

Competencies
• Agentic AI solution design
• Drug information extraction and summarization
• Health authority source interpretation
• KPI-based product information structuring
• Generative AI summarization workflows
• Human-in-the-loop review and governance


At a glance

https://catalogartifact.azureedge.net/publicartifacts/hcl-technologies.hcltech_irp_drug_summary_agents-7f858190-32f7-49ed-9918-e7d63725c776/image2_DrugSumm.png